BT5528
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BT5528, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression [Phase 1, Phase 2]